Peer review reports
From: Transparency and reporting characteristics of COVID-19 randomized controlled trials
Original Submission | ||
---|---|---|
19 Feb 2022 | Submitted | Original manuscript |
19 Mar 2022 | Reviewed | Reviewer Report |
25 Mar 2022 | Reviewed | Reviewer Report - Ross Mounce |
31 Mar 2022 | Reviewed | Reviewer Report |
3 Apr 2022 | Reviewed | Reviewer Report |
5 Apr 2022 | Reviewed | Reviewer Report |
23 May 2022 | Author responded | Author comments - Philipp Kapp |
Resubmission - Version 2 | ||
23 May 2022 | Submitted | Manuscript version 2 |
21 Jul 2022 | Author responded | Author comments - Philipp Kapp |
Resubmission - Version 3 | ||
21 Jul 2022 | Submitted | Manuscript version 3 |
10 Sep 2022 | Author responded | Author comments - Philipp Kapp |
Resubmission - Version 4 | ||
10 Sep 2022 | Submitted | Manuscript version 4 |
Publishing | ||
13 Sep 2022 | Editorially accepted | |
26 Sep 2022 | Article published | 10.1186/s12916-022-02567-y |